Biomarin Pharmaceutical (BMRN) Asset Utilization Ratio (2010 - 2026)
Biomarin Pharmaceutical (BMRN) posted Asset Utilization Ratio of 0.4 for Q1 2026, down 5.42% on a QoQ basis from 0.42 in Q4 2025, and down 4.01% year-over-year from 0.42 in Q1 2025.
Biomarin Pharmaceutical (BMRN) Asset Utilization Ratio (2010 - 2026) Analysis & Trends
Biomarin Pharmaceutical's Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.4 for Q1 2026.
- Quarterly Asset Utilization Ratio fell 4.01% year-over-year to 0.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.4 (down 4.01% YoY) and the FY2025 annual result came in at 0.44, up 7.05% from the prior year.
- Asset Utilization Ratio was 0.4 for Q1 2026 at Biomarin Pharmaceutical, down from 0.42 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.42 in Q4 2025 and bottomed at 0.31 in Q1 2022.
- A 5-year average of 0.37 and a median of 0.36 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio decreased 4.38% — and 2024, when it grew 15.92%.
- Biomarin Pharmaceutical's Asset Utilization Ratio stood at 0.33 in 2022, then climbed by 7.27% to 0.36 in 2023, then advanced by 15.92% to 0.41 in 2024, then rose by 2.71% to 0.42 in 2025, then slipped by 5.42% to 0.4 in 2026.
- Business Quant data shows BMRN's Asset Utilization Ratio at 0.4 in Q1 2026, 0.42 in Q4 2025, and 0.41 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Biomarin Pharmaceutical | 11.33 Bn | 9.11 Bn | 571.21 Mn | 0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.40 |
| Dec 31, 2025 | 0.42 |
| Sep 30, 2025 | 0.41 |
| Jun 30, 2025 | 0.42 |
| Mar 31, 2025 | 0.42 |
| Dec 31, 2024 | 0.41 |
| Sep 30, 2024 | 0.40 |
| Jun 30, 2024 | 0.37 |
| Mar 31, 2024 | 0.36 |
| Dec 31, 2023 | 0.36 |
| Sep 30, 2023 | 0.35 |
| Jun 30, 2023 | 0.34 |
| Mar 31, 2023 | 0.34 |
| Dec 31, 2022 | 0.33 |
| Sep 30, 2022 | 0.32 |
| Jun 30, 2022 | 0.31 |
| Mar 31, 2022 | 0.31 |
| Dec 31, 2021 | 0.31 |
| Sep 30, 2021 | 0.31 |
| Jun 30, 2021 | 0.33 |